ITCI - Intracellular Th - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Intracellular Th's activity chart (see below) currently has 318 price targets and 219 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 90.06% of the time, taking 370.08 days on average.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 02-Apr-2025. First documented stock forecast 14-Apr-2015.

Best performing analysts who are covering ITCI - Intracellular Th:

Sumant Kulkarni Robert Hazlett Seamus Fernandez Andrew Tsai Charles Duncan Adnan Butt

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Apr-2025

$132

$132

1 years 7 months 18 days ago
(02-Apr-2025)

26/28 (92.86%)

$0.13 (0.10%)

512

Hold Since 28-Feb-2025

$132

$132

1 years 8 months 23 days ago
(28-Feb-2025)

12/14 (85.71%)

$3.8 (2.96%)

738

Buy Since 10-Dec-2020

$132

$140

1 years 8 months 27 days ago
(24-Feb-2025)

14/16 (87.5%)

$3.43 (2.67%)

274

Hold Since 21-Feb-2025

$100

1 years 8 months 30 days ago
(21-Feb-2025)

24/25 (96%)

$-27.19 (-21.38%)

152

Hold Since 08-Aug-2024

$132

$87

1 years 9 months 15 days ago
(05-Feb-2025)

7/8 (87.5%)

$4.97 (3.91%)

209

Show more analysts

Please expand the browser size to see the chart

What is ITCI (Intracellular Th) average time for price targets to be met?

On average it took 370 days for the stock forecasts to be reached, with an average price target met ratio of 90.06%.

Which analyst most recently updated their price target on ITCI (Intracellular Th)?

Charles Duncan

Which analyst has the most public recommendations on ITCI (Intracellular Th)?

Charles Duncan works at CANTOR FITZGERALD and has 5 price targets and 12 ratings on ITCI

Which analyst is the currently most bullish on ITCI (Intracellular Th)?

David Amsellem with the highest potential upside of $0.13

Which analyst is the currently most reserved on ITCI (Intracellular Th)?

Paul Matteis with the lowest potential downside of -$110.87
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?